| VALEANT PHARMACEUTICALS INTERNATIONAL | | | | | | | | | |
| Security | | | 91911K102 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | VRX | | | | | | Meeting Date | | | 30-Apr-2018 | |
| ISIN | | | | CA91911K1021 | | | | | Agenda | | | 934744269 - Management | |
| Record Date | | | 05-Mar-2018 | | | | | | | Holding Recon Date | 05-Mar-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 25-Apr-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1a. | Election of Director: Richard U. DeSchutter | | Management | | For | | For | | |
| 1b. | Election of Director: D. Robert Hale | | Management | | For | | For | | |
| 1c. | Election of Director: Dr. Argeris (Jerry) N. Karabelas | Management | | For | | For | | |
| 1d. | Election of Director: Sarah B. Kavanagh | | Management | | For | | For | | |
| 1e. | Election of Director: Joseph C. Papa | | Management | | For | | For | | |
| 1f. | Election of Director: John A. Paulson | | Management | | For | | For | | |
| 1g. | Election of Director: Robert N. Power | | Management | | For | | For | | |
| 1h. | Election of Director: Russel C. Robertson | | Management | | For | | For | | |
| 1i. | Election of Director: Thomas W. Ross, Sr. | | Management | | For | | For | | |
| 1j. | Election of Director: Amy B. Wechsler, M.D. | | Management | | For | | For | | |
| 2. | The approval, in an advisory resolution, of the compensation of our Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement. | Management | | For | | For | | |
| 3. | The approval of an amendment to the Company's 2014 Omnibus Incentive Plan to increase the number of Common Shares authorized under such plan. | Management | | For | | For | | |
| 4. | To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2019 Annual Meeting of Shareholders and to authorize the Company's Board of Directors to fix the auditors' remuneration. | Management | | For | | For | | |
| MBIA INC. | | | | | | | | | | | | | | |
| Security | | | 55262C100 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | MBI | | | | | | | Meeting Date | | | 02-May-2018 | |
| ISIN | | | | US55262C1009 | | | | | Agenda | | | 934747227 - Management | |
| Record Date | | | 08-Mar-2018 | | | | | | | Holding Recon Date | 08-Mar-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 01-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1a. | Election of Director: Francis Y. Chin | | Management | | For | | For | | |
| 1b. | Election of Director: William C. Fallon | | Management | | For | | For | | |
| 1c. | Election of Director: Steven J. Gilbert | | Management | | For | | For | | |
| 1d. | Election of Director: Charles R. Rinehart | | Management | | For | | For | | |
| 1e. | Election of Director: Theodore Shasta | | Management | | For | | For | | |
| 1f. | Election of Director: Richard C. Vaughan | | Management | | For | | For | | |
| 2. | To approve, on an advisory basis, executive compensation. | Management | | For | | For | | |
| 3. | To ratify the selection of PricewaterhouseCoopers LLP, certified public accountants, as independent auditors for the Company for the year 2018. | Management | | For | | For | | |
| 4. | To ratify the adoption of an amendment to MBIA Inc.'s By-Laws approved by the Board of Directors on February 13, 2018. | Management | | For | | For | | |
| SEARS HOLDINGS CORPORATION | | | | | | | | | | |
| Security | | | 812350106 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | SHLD | | | | | | Meeting Date | | | 09-May-2018 | |
| ISIN | | | | US8123501061 | | | | | | Agenda | | | 934756238 - Management | |
| Record Date | | | 12-Mar-2018 | | | | | | | Holding Recon Date | 12-Mar-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 08-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1. | DIRECTOR | | | | | | Management | | | | | | |
| | | 1 | Paul G. DePodesta | | | | | | For | | For | | |
| | | 2 | Kunal S. Kamlani | | | | | | For | | For | | |
| | | 3 | William C. Kunkler, III | | | | | For | | For | | |
| | | 4 | Edward S. Lampert | | | | | | For | | For | | |
| | | 5 | Ann N. Reese | | | | | | | For | | For | | |
| | | 6 | Thomas J. Tisch | | | | | | | For | | For | | |
| 2. | Advisory vote to approve the compensation of our named executive officers. | Management | | For | | For | | |
| 3. | Ratify the appointment by the Audit Committee of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2018. | Management | | For | | For | | |
| 4. | Stockholder proposal regarding an independent Chair of the Board of Directors. | Shareholder | | For | | Against | | |
| OVERSTOCK.COM, INC. | | | | | | | | | | | |
| Security | | | 690370309 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | OSTBP | | | | | | Meeting Date | | | 09-May-2018 | |
| ISIN | | | | US6903703097 | | | | | | Agenda | | | 934758232 - Management | |
| Record Date | | | 12-Mar-2018 | | | | | | | Holding Recon Date | 12-Mar-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 08-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1. | DIRECTOR | | | | | | Management | | | | | | |
| | | 1 | Patrick M. Byrne | | | | | | | For | | For | | |
| | | 2 | Barclay F. Corbus | | | | | | For | | For | | |
| | | 3 | Jonathan E. Johnson III | | | | | For | | For | | |
| 2. | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2018. | Management | | For | | For | | |
| ASCENT CAPITAL GROUP, INC. | | | | | | | | | | | |
| Security | | | 043632108 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | ASCMA | | | | | | Meeting Date | | | 11-May-2018 | |
| ISIN | | | | US0436321089 | | | | | | Agenda | | | 934753585 - Management | |
| Record Date | | | 14-Mar-2018 | | | | | | | Holding Recon Date | 14-Mar-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 10-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1. | DIRECTOR | | | | | | Management | | | | | | |
| | | 1 | Thomas P. McMillin | | | | | | For | | For | | |
| 2. | A proposal to ratify the selection of KPMG LLP as our independent auditors for the fiscal year ending December 31, 2018. | Management | | For | | For | | |
| SEARS HOMETOWN AND OUTLET STORES, INC. | | | | | | | | | |
| Security | | | 812362101 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | SHOS | | | | | | Meeting Date | | | 23-May-2018 | |
| ISIN | | | | US8123621018 | | | | | | Agenda | | | 934800447 - Management | |
| Record Date | | | 03-Apr-2018 | | | | | | | Holding Recon Date | 03-Apr-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 22-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1. | DIRECTOR | | | | | | Management | | | | | | |
| | | 1 | E.J. Bird | | | | | | | For | | For | | |
| | | 2 | James F. Gooch | | | | | | | For | | For | | |
| | | 3 | Josephine Linden | | | | | | For | | For | | |
| | | 4 | Kevin Longino | | | | | | | For | | For | | |
| | | 5 | William K. Phelan | | | | | | For | | For | | |
| | | 6 | Will Powell | | | | | | | For | | For | | |
| | | 7 | David Robbins | | | | | | | For | | For | | |
| 2. | Approve, on an advisory basis, the compensation of our Named Executive Officers. | Management | | For | | For | | |
| 3. | Ratify the appointment by the Audit Committee of BDO USA, LLP as the Company's independent registered public accounting firm for fiscal year 2018. | Management | | For | | For | | |
| RESOLUTE FOREST PRODUCTS INC. | | | | | | | | | |
| Security | | | 76117W109 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | RFP | | | | | | Meeting Date | | | 25-May-2018 | |
| ISIN | | | | US76117W1099 | | | | | Agenda | | | 934803809 - Management | |
| Record Date | | | 29-Mar-2018 | | | | | | | Holding Recon Date | 29-Mar-2018 | |
| City / | Country | | | / | Canada | | | | | Vote Deadline Date | | 24-May-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| | | | | | | | | | | | | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1.1 | Election of directors: Randall C. Benson | | Management | | For | | For | | |
| 1.2 | Jennifer C. Dolan | | | | Management | | For | | For | | |
| 1.3 | Richard D. Falconer | | | | Management | | For | | For | | |
| 1.4 | Jeffrey A. Hearn | | | | | Management | | For | | For | | |
| 1.5 | Yves Laflamme | | | | | Management | | For | | For | | |
| 1.6 | Bradley P. Martin | | | | Management | | For | | For | | |
| 1.7 | Alain Rhéaume | | | | | Management | | For | | For | | |
| 1.8 | Michael S. Rousseau | | | | Management | | For | | For | | |
| 2 | Ratification of PricewaterhouseCoopers LLP appointment. | Management | | For | | For | | |
| 3 | Advisory vote to approve executive compensation ("say- on-pay"). | Management | | For | | For | | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | | | | | | | | | |
| Security | | | 881624209 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | TEVA | | | | | | Meeting Date | | | 05-Jun-2018 | |
| ISIN | | | | US8816242098 | | | | | | Agenda | | | 934801778 - Management | |
| Record Date | | | 13-Apr-2018 | | | | | | | Holding Recon Date | 13-Apr-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 04-Jun-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1A | Election of Director: Rosemary A. Crane | | Management | | For | | For | | |
| 1B | Election of Director: Gerald M. Lieberman | | Management | | For | | For | | |
| 1C | Election of Director: Professor Ronit Satchi-Fainaro | Management | | For | | For | | |
| 2. | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | Management | | For | | For | | |
| 3. | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | Management | | For | | For | | |
| 4. | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until the 2019 annual meeting of shareholders. | Management | | For | | For | | |
| 5. | To approve an amendment and restatement of Teva's 2008 Employee Stock Purchase Plan for U.S. Employees. | Management | | For | | For | | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | | | | | | | | | |
| Security | | | 881624209 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | TEVA | | | | | | Meeting Date | | | 05-Jun-2018 | |
| ISIN | | | | US8816242098 | | | | | | Agenda | | | 934817694 - Management | |
| Record Date | | | 26-Apr-2018 | | | | | | | Holding Recon Date | 26-Apr-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 04-Jun-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1.1 | Election of Director: Rosemary A. Crane | | Management | | For | | For | | |
| 1.2 | Election of Director: Gerald M. Lieberman | | Management | | For | | For | | |
| 1.3 | Election of Director: Professor Ronit Satchi-Fainaro | Management | | For | | For | | |
| 2. | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers. | Management | | For | | For | | |
| 3. | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years. | Management | | For | | For | | |
| 4. | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until the 2019 annual meeting of shareholders. | Management | | For | | For | | |
| 5. | To approve an amendment and restatement of Teva's 2008 Employee Stock Purchase Plan for U.S. Employees. | Management | | For | | For | | |
| ENDO INTERNATIONAL PLC | | | | | | | | | | | |
| Security | | | G30401106 | | | | | | | Meeting Type | | | Annual | |
| Ticker Symbol | | ENDP | | | | | | Meeting Date | | | 07-Jun-2018 | |
| ISIN | | | | IE00BJ3V9050 | | | | | | Agenda | | | 934799947 - Management | |
| Record Date | | | 13-Apr-2018 | | | | | | | Holding Recon Date | 13-Apr-2018 | |
| City / | Country | | | / | United States | | | | | Vote Deadline Date | | 06-Jun-2018 | |
| SEDOL(s) | | | | | | | | | | Quick Code | | | | |
| Item | Proposal | | | | | | Proposed by | Vote | For/Against Management | |
| 1a. | Election of Director: Roger H. Kimmel | | Management | | For | | For | | |
| 1b. | Election of Director: Paul V. Campanelli | | Management | | For | | For | | |
| 1c. | Election of Director: Shane M. Cooke | | Management | | For | | For | | |
| 1d. | Election of Director: Nancy J. Hutson, Ph.D. | | Management | | For | | For | | |
| 1e. | Election of Director: Michael Hyatt | | Management | | For | | For | | |
| 1f. | Election of Director: Sharad S. Mansukani, M.D. | Management | | For | | For | | |
| 1g. | Election of Director: William P. Montague | | Management | | For | | For | | |
| 1h. | Election of Director: Todd B. Sisitsky | | Management | | For | | For | | |
| 2. | To approve the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2018 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm's remuneration. | Management | | For | | For | | |
| 3. | To approve, by advisory vote, named executive officer compensation. | Management | | For | | For | | |
| 4. | To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan. | Management | | For | | For | | |
| 5. | To renew the Board's existing authority to issue shares under Irish law. | Management | | For | | For | | |
| 6. | To renew the Board's existing authority to opt-out of statutory pre-emption rights under Irish law. | Management | | For | | For | | |